tirzepatide research A 3-year study of in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 Tirzepatide — Research Peptide (Lyophilised,

When selecting a GLP-1, its important to consider: How easily can you get refills Whether the medication fits your budget Whether your doctor can monitor progress regularly If your lifestyle supports the required dosing schedule Choosing a medicine you cannot continue long-term leads to interrupted progress, which slows results

This helps reduce side effects and allows your body to adjust comfortably

Finally, the translational relevance of the 100 nM dose remains uncertain due to discrepancies with clinical pharmacokinetics, and the clinical safety at this dose under long-term use still needs to be further evaluated

A matched study from SUSTAIN 6 and REWIND demonstrated that semaglutide reduced to 3-point MACE by 26% compared to dulaglutide, although the reduction was not statistically significant 12

doi: 10.1021/ja011774y